Puhua International Hospitals, Beijing: New Anti-aging Study

Puhua International Hospitals-Temple of Heaven, Beijing, Launches Anti-aging Biotherapy Study.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Tomorrow's Health Care: TODAY

Beijing, China (PRWEB) (PRWEB) May 15, 2013

Puhua International Hospitals (PIHs)-Temple of Heaven (http://puhuahospital.com) (http://www.puhuachina.com) has been a leading international neuroscience and biotechnology center in Beijing, China, for the past 20 years. During that time, Puhua has built and maintained a dominant presence in Beijing in the areas of applied biotechnology, neurology, neurosurgery, medicine, cancer, traditional Chinese medicine (TCM) and surgery. PIH also has vigorous programs of Integrative Oncology and Diabetes.

Over the past decade Puhua International Hospitals-Temple of Heaven has made huge strides forward in applied cellular biotechnology (stem cell therapy, or SCT). Thus, in addition to its high level of diagnostic and therapeutic expertise, PIH has become a world leader in applied biotechnology, cellular science and applied stem cell technology.

It is in these areas of applied clinical research that remarkable progress is being made in the areas of: spinal cord repair; post-traumatic brain injury; cerebral palsy; Parkinson’s disease; cerebral-vascular and cardio-vascular disease, and diabetes. By utilizing cellular/regenerative medicine and biotechnology at the time of surgical repair for spinal cord and brain injury, the neurosurgeons and clinical scientists at Puhua International are today redefining what is now possible in terms of recovery from neurological injury and disease.

Whereas traditional SCT utilizes donor cell-lines, newer technologies using autologous stem cells (meaning stem cell lines derived from the patients) are now also being successfully employed. Autologous cellular therapy is extremely safe and cost-effective for younger (under 40 years of age) patients with diagnoses such as: cerebral palsy, anoxic encephalopathy, autism, diabetes and many other conditions.

Puhua International Hospitals-Temple of Heaven, Beijing (http://puhuahospital.com) (http://www.puhuachina.com) is a Center of Excellence in neurology and neurosurgery as well as a leader on the frontier of applied cellular science and biotechnology.

James T. Quinlan, MD, is an American physician, trained at the University of Iowa, with a life-long interest and commitment to the subject of wellness, regenerative medicine and anti-aging. He is heading the initiative at Puhua International Hospitals (PIH)-Temple of Heaven to apply what has been learned in the past decade of applied stem cell science to the important and fascinating frontier of Anti-aging Medicine.

What is meant by “old age?” The concept of “being old” is quite relative. In fact, in a world of aging people, people who can now expect to live to 80, it becomes critically important to attempt to both better define the terms, and to lay out those elements that may be improved by current medical bio-technology. This imperative derives both from first principles: to attend to the health and happiness of the individual. However, since it is now possible to pre-empt many of the diseases of aging by cellular biotechnologies, it is time to re-examine and re-define what it means to “age normally.”

In other words, does the normal process of aging need to include the diseases of aging? Perhaps it does not, or at least not the way that it used to. Further, it is also necessary to look for ways to keep aging populations as healthy as possible. Not only is this the right thing to do, but we actually have no alternative. There is simply not enough carrying capacity (to use an environmental idiom) to sustain a planet over-populated by people who are sick and infirm from the diseases of aging.

So, what is “aging,” and what is meant by “normal?” What are the current options?

Simply stated, aging is what happens to an individual, living in an environment, over the course of time. From this moment forward, for those seriously interested in anti-aging and regenerative therapies, the questions are few and they are simple: what can one do when seriously looking at anti-aging strategies today?

Some patients age sooner than others: all age in different ways, but all age as the stem cell lines grow old and lose vigor. In an ideal world, patients would have their own stem cells banked at birth, and these cells would be available to top up and reset our own stem cell lines later in life. Unfortunately, nobody reading this has the opportunity to benefit from that choice today, and it will be many decades before this scenario is available to patients.

The Anti-aging Service at Puhua International Hospitals (PIHs)-Temple of Heaven is studying the use of cultured and purified pluri-potent donor mesenchymal stem cells (from donor placental cord blood) to reset systemic stem cell lines and thereby address the diseases of aging (most of which are the result of a gradual failure in numbers and capacity of the original cell lines themselves). Our scientists are now able to isolate, purify and amplify these donor stem cells in the lab, and infuse them into the patient by means of a simple IV in about 15 minutes. Thus a simple technological solution is today available.

The human stem cells themselves are the stars in this process: their extremely low antigenicity and their predilection to go to where they are needed, to blend in and work with the host’s original stem cells makes the process quite workable.

After treating thousands of patients with mesenchymal stem cells, scientists know that this technique is safe and effective. Still, not every question has been answered. Thus, while offering an anti aging stem cell channel, Puhua International is coupling this therapy to a prospective clinical study.

Just as Puhua is excited to be on the forefront of applied biotechnology in terms of its autologous MNCs program for younger patients, so we are today deeply committed to the search for solutions to the problems of anti aging cellular medicine.

For testimonials and further information, please send an email.

These new therapies, and ongoing efforts to best understand them, underscore and highlight the expanding mission of Puhua International Hospitals-Temple of Heaven. While it has always been a Center of Excellence in neurology and neurosurgery, PIH has also grown into a fully licensed, full-service hospital with over 60 inpatient beds, busy operating rooms and a fully-staffed, all imaging options, contemporary surgery suites and a Western-standard ICU.

Puhua International Hospitals-Temple of Heaven cares for both adults and children in Beijing, as does its full service outpatient clinic (Puhua International Hospitals-Shuangjing) (http://www.puhuaclinic.com) which has been open for ambulatory care since 2010.

Puhua International Hospitals-TEDA, Tianjin, opened in 2012 to serve cardio-vascular-related disorders in coordination with the TEDA International Cardiac Hospital (TICH) in Tianjin.

Puhua International Hospitals-Temple of Heaven, Beijing (http://puhuahospital.com) (http://www.puhuachina.com), is a dynamic, respected and forward-driving community of excellence dedicated to one simple mission: to bring to each patient today the best of the health care of tomorrow.

Puhua International Hospitals may be contacted directly by calling +86-10-670355566 (Beijing), by writing to info(at)puhuachina(dot)com, or by visiting the websites at ((http://puhuahospital.com) and (http://www.puhuachina.com). Additional information regarding Puhua International Hospitals may be found at Wikipedia (http://www.wikipedia.com), You Tube (http://www.youtube.com), and Face Book (http://www.facebook.com).


Contact

  • James Quinlan
    jtquinlan@gmail.com
    +86-10-67061799
    Email

Attachments